CLGM
EW icon

Capitolis Liquid Global Markets’s Edwards Lifesciences EW Stock Holding History

Capitolis Liquid Global Markets’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.97M Buy
99,528
+78,261
+368% +$6.45M 0.05% 203
2025
Q4 		$1.81M Buy
+21,267
New +$1.75M 0.01% 283

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capitolis Liquid Global Markets's EW Position: Q1 2026 in Review

Capitolis Liquid Global Markets increased its Edwards Lifesciences (EW) stake by 368% in Q1 2026, buying an estimated $6.45M and bringing the position to 99,528 shares worth $7.97M. The position accounts for 0.05% of the portfolio, ranked #203.

Capitolis Liquid Global Markets first reported a position in EW in Q4 2025 and has held it in 2 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Capitolis Liquid Global Markets held 99,528 shares of Edwards Lifesciences worth $7.97M as of Q1 2026.
  • Capitolis Liquid Global Markets bought 78,261 Edwards Lifesciences shares in Q1 2026, an estimated $6.45M.
  • Edwards Lifesciences made up 0.05% of Capitolis Liquid Global Markets's portfolio in Q1 2026, its #203 holding.
  • Capitolis Liquid Global Markets first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 2 quarters since.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q1 2026, filed 15 May 2026.